Literature DB >> 23240550

A thermoresponsive bubble-generating liposomal system for triggering localized extracellular drug delivery.

Ko-Jie Chen1, Hsiang-Fa Liang, Hsin-Lung Chen, Yucai Wang, Po-Yuan Cheng, Hao-Li Liu, Younan Xia, Hsing-Wen Sung.   

Abstract

The therapeutic effectiveness of chemotherapy is optimal only when tumor cells are subjected to a maximum drug exposure. To increase the intratumoral drug concentration and thus the efficacy of chemotherapy, a thermoresponsive bubble-generating liposomal system is proposed for triggering localized extracellular drug delivery. The key component of this liposomal formulation is the encapsulated ammonium bicarbonate (ABC), which is used to create the transmembrane gradient needed for a highly efficient encapsulation of doxorubicin (DOX). At an elevated temperature (42 °C), decomposition of ABC generates CO(2) bubbles, creating permeable defects in the lipid bilayer that rapidly release DOX and instantly increase the drug concentration locally. Because the generated CO(2) bubbles are hyperechogenic, they also enhance ultrasound imaging. Consequently, this new liposomal system encapsulated with ABC may also provide an ability to monitor a temperature-controlled drug delivery process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23240550     DOI: 10.1021/nn304474j

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  33 in total

Review 1.  Stimuli-responsive nanocarriers for drug delivery.

Authors:  Simona Mura; Julien Nicolas; Patrick Couvreur
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

Review 2.  Design strategies for physical-stimuli-responsive programmable nanotherapeutics.

Authors:  Fitsum Feleke Sahle; Muhammad Gulfam; Tao L Lowe
Journal:  Drug Discov Today       Date:  2018-04-10       Impact factor: 7.851

3.  A targeted approach to cancer imaging and therapy.

Authors:  Chun Li
Journal:  Nat Mater       Date:  2014-02       Impact factor: 43.841

4.  Cucurbit[7]uril Enables Multi-Stimuli-Responsive Release from the Self-Assembled Hydrophobic Phase of a Metal Organic Polyhedron.

Authors:  Soumen K Samanta; Jeffrey Quigley; Brittany Vinciguerra; Volker Briken; Lyle Isaacs
Journal:  J Am Chem Soc       Date:  2017-06-23       Impact factor: 15.419

5.  Real-Time Monitoring of ATP-Responsive Drug Release Using Mesoporous-Silica-Coated Multicolor Upconversion Nanoparticles.

Authors:  Jinping Lai; Birju P Shah; Yixiao Zhang; Letao Yang; Ki-Bum Lee
Journal:  ACS Nano       Date:  2015-04-15       Impact factor: 15.881

Review 6.  Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.

Authors:  Abhirup Mandal; Dhananjay Pal; Vibhuti Agrahari; Hoang My Trinh; Mary Joseph; Ashim K Mitra
Journal:  Adv Drug Deliv Rev       Date:  2018-01-13       Impact factor: 15.470

7.  ATP-responsive DNA-graphene hybrid nanoaggregates for anticancer drug delivery.

Authors:  Ran Mo; Tianyue Jiang; Wujin Sun; Zhen Gu
Journal:  Biomaterials       Date:  2015-02-14       Impact factor: 12.479

Review 8.  Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors:  Yuzhe Sun; Edward Davis
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

9.  Electroresponsive Nanoparticles Improve Antiseizure Effect of Phenytoin in Generalized Tonic-Clonic Seizures.

Authors:  Yi Wang; Xiaoying Ying; Liying Chen; Yao Liu; Ying Wang; Jiao Liang; Cenglin Xu; Yi Guo; Shuang Wang; Weiwei Hu; Yongzhong Du; Zhong Chen
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

Review 10.  Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.

Authors:  Mahdi Karimi; Amir Ghasemi; Parham Sahandi Zangabad; Reza Rahighi; S Masoud Moosavi Basri; H Mirshekari; M Amiri; Z Shafaei Pishabad; A Aslani; M Bozorgomid; D Ghosh; A Beyzavi; A Vaseghi; A R Aref; L Haghani; S Bahrami; Michael R Hamblin
Journal:  Chem Soc Rev       Date:  2016-03-07       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.